| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $955.2M | $759.2M | $579.9M |
| YoY Revenue Growth % | +25.8% | +30.9% | — |
| Gross Profit | $834.5M | $674.1M | — |
| Gross Margin % | 87.4% | 88.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$70.5M | -$142.7M | -$187.4M |
| Operating Margin % | -7.4% | -18.8% | -32.3% |
| Net Income (GAAP) | -$58.6M | -$5.2M | -$424.2M |
| EBITDA (Normalized) | -$61.8M | -$139.7M | -$166.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $232.9M | -$64.0M | $35.0M |
| Capital Expenditures (CapEx) | $10.8M | $3.8M | $26.1M |
| Free Cash Flow (FCF) | $222.0M | -$67.7M | $8.9M |
| FCF Margin % | 23.2% | -8.9% | 1.5% |
| Return on Invested Capital (ROIC %) | -5.2% | -13.9% | -4.7% |
| Cash & Short-Term Equivalents | $229.6M | $227.6M | — |
| Total Debt (Short + Long Term) | $308.9M | $260.1M | $1.21B |
| Total Stockholders' Equity | $990.7M | $775.9M | $2.49B |